RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Edward L. Davis to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications Edward L. Davis has written about Cyclin-Dependent Kinase Inhibitor p21.
Edward L. Davis
Connection Strength
0.042
Cyclin-Dependent Kinase Inhibitor p21
  1. Zhang Z, Garzotto M, Davis EW, Mori M, Stoller WA, Farris PE, Wong CP, Beaver LM, Thomas GV, Williams DE, Dashwood RH, Hendrix DA, Ho E, Shannon J. Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial. Nutr Cancer. 2020; 72(1):74-87.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support